Stem Cell (BM)   
Endothelial Progenitor Cell Therapy for the Treatment of Coronary Disease, Acute Mi, and Pulmonary Arterial Hypertension: Current Perspectives
Catheter Cardiovasc Interv (2007) 70;983-98
M. R. Ward, et al.
Intracoronary Administration of Autologous Adipose Tissue-Derived Stem Cells Improves Left Ventricular Function, Perfusion, and Remodelling after Acute Myocardial Infarction
Eur Heart J (2007) 28;2667-77
C. Valina, et al.
Prospective Randomized Trial of Direct Endomyocardial Implantation of Bone Marrow Cells for Treatment of Severe Coronary Artery Diseases (Protect-Cad Trial)
Eur Heart J (2007) 28;2998-3005
H. F. Tse, et al.
Comparative Evaluation of Long-Term Clinical Efficacy with Catheter-Based Percutaneous Intramyocardial Autologous Bone Marrow Cell Implantation Versus Laser Myocardial Revascularization in Patients with Severe Coronary Artery Disease
Am Heart J (2007) 154;982 e1-6
H. F. Tse, et al.
Local Delivery of Protease-Resistant Stromal Cell Derived Factor-1 for Stem Cell Recruitment after Myocardial Infarction
Circulation (2007) 116;1683-92
V. F. Segers, et al.
Bone Marrow Derived Mesenchymal Cell Mobilization by Granulocyte-Colony Stimulating Factor after Acute Myocardial Infarction: Results from the Stem Cells in Myocardial Infarction (Stemmi) Trial
Circulation (2007) 116;I24-30
R. S. Ripa, et al.
One-Day Kinetics of Myocardial Engraftment after Intracoronary Injection of Bone Marrow Mononuclear Cells in Patients with Acute and Chronic Myocardial Infarction
Heart (2007) 93;837-41
M. Penicka, et al.
Intracoronary Injection of Autologous Bone Marrow-Derived Mononuclear Cells in Patients with Large Anterior Acute Myocardial Infarction: A Prematurely Terminated Randomized Study
J Am Coll Cardiol (2007) 49;2373-4
M. Penicka, et al.
Design and Rationale for the Myocardial Stem Cell Administration after Acute Myocardial Infarction (Mystar) Study: A Multicenter, Prospective, Randomized, Single-Blind Trial Comparing Early and Late Intracoronary or Combined (Percutaneous Intramyocardial and Intracoronary) Administration of Nonselected Autologous Bone Marrow Cells to Patients after Acute Myocardial Infarction
Am Heart J (2007) 153;212 e1-7
N. Nyolczas, et al.
Pilot Study to Evaluate the Safety and Feasibility of Intracoronary Cd133(+) and Cd133(-) Cd34(+) Cell Therapy in Patients with Nonviable Anterior Myocardial Infarction
Catheter Cardiovasc Interv (2007) 69;773-81
A. Manginas, et al.
Exercise Capacity and Quality of Life after Intracoronary Injection of Autologous Mononuclear Bone Marrow Cells in Acute Myocardial Infarction: Results from the Autologous Stem Cell Transplantation in Acute Myocardial Infarction (Astami) Randomized Controlled Trial
Am Heart J (2007) 154;710 e1-8
K. Lunde, et al.
Differentiation, Survival, and Function of Embryonic Stem Cell Derived Endothelial Cells for Ischemic Heart Disease
Circulation (2007) 116;I46-54
Z. Li, et al.
Human Embryonic Stem Cell Transplantation to Repair the Infarcted Myocardium
Heart (2007) 93;1278-84
J. Leor, et al.
Effects of Triple Antiplatelet Therapy (Aspirin, Clopidogrel, and Cilostazol) on Platelet Aggregation and P-Selectin Expression in Patients Undergoing Coronary Artery Stent Implantation
Am J Cardiol (2007) 100;610-4
B. K. Lee, et al.
Effects of Stem Cell Therapy with G-Csf on Coronary Artery after Drug-Eluting Stent Implantation in Patients with Acute Myocardial Infarction
Heart (2007)
H. J. Kang, et al.
Intracoronary Infusion of the Mobilized Peripheral Blood Stem Cell by G-Csf Is Better Than Mobilization Alone by G-Csf for Improvement of Cardiac Function and Remodeling: 2-Year Follow-up Results of the Myocardial Regeneration and Angiogenesis in Myocardial Infarction with G-Csf and Intra-Coronary Stem Cell Infusion (Magic Cell) 1 Trial
Am Heart J (2007) 153;237 e1-8
H. J. Kang, et al.
A Placebo Controlled, Dose-Ranging, Safety Study of Allogenic Mesenchymal Stem Cells Injected by Endomyocardial Delivery after an Acute Myocardial Infarction
Eur Heart J (2008) 29;251-9
S. M. Hashemi, et al.
Restoration of Microvascular Function in the Infarct-Related Artery by Intracoronary Transplantation of Bone Marrow Progenitor Cells in Patients with Acute Myocardial Infarction: The Doppler Substudy of the Reinfusion of Enriched Progenitor Cells and Infarct Remodeling in Acute Myocardial Infarction (Repair-Ami) Trial
Circulation (2007) 116;366-74
S. Erbs, et al.
Transendocardial Autologous Bone Marrow in Chronic Myocardial Infarction Using a Helical Needle Catheter: 1-Year Follow-up in an Open-Label, Nonrandomized, Single-Center Pilot Study (the Tabmmi Study)
Am Heart J (2007) 154;79 e1-7
L. M. de la Fuente, et al.
Subacute Cardiac Toxicity Following Autologous Haemopoietic Stem-Cell Transplantation in Patients with Normal Cardiac Function
Heart (2007)
T. Chung, et al.
Age Decreases Endothelial Progenitor Cell Recruitment through Decreases in Hypoxia-Inducible Factor 1alpha Stabilization During Ischemia
Circulation (2007) 116;2818-29
E. I. Chang, et al.
Intramyocardial Injection of Autologous Bone Marrow Mononuclear Cells in Patients with Chronic Myocardial Infarction and Severe Left Ventricular Dysfunction
Am J Cardiol (2007) 100;1094-8
S. L. Beeres, et al.
Iron-Oxide Labeling and Outcome of Transplanted Mesenchymal Stem Cells in the Infarcted Myocardium
Circulation (2007) 116;I38-45
Y. Amsalem, et al.
The Final 10-Year Follow-up Results from the Bari Randomized Trial
J Am Coll Cardiol (2007) 49;1600-6
.